Related references
Note: Only part of the references are listed.Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Mechanisms that link the oncogenic epithelial-mesenchymal transition to suppression of anoikis
Steven M. Frisch et al.
JOURNAL OF CELL SCIENCE (2013)
TrkB/BDNF signaling pathway is a potential therapeutic target for pulmonary large cell neuroendocrine carcinoma
Seiichi Odate et al.
LUNG CANCER (2013)
BDNF/TrkB signaling protects HT-29 human colon cancer cells from EGFR inhibition
Caroline Brunetto de Farias et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
The EMT signaling pathways in endometrial carcinoma
Eva Colas et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2012)
Risk factors for recurrence amongst high intermediate risk patients with endometrioid adenocarcinoma
Agnes Y. Bahng et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2012)
Markers for individualised therapy in endometrial carcinoma
Helga B. Salvesen et al.
LANCET ONCOLOGY (2012)
Expression of TrkB and BDNF is associated with poor prognosis in non-small cell lung cancer
Kyoko Okamura et al.
LUNG CANCER (2012)
A Novel Role for BDNF-TrkB in the Regulation of Chemotherapy Resistance in Head and Neck Squamous Cell Carcinoma
Junegoo Lee et al.
PLOS ONE (2012)
Inhibition of Uterine Sarcoma Cell Growth through Suppression of Endogenous Tyrosine Kinase B Signaling
Kenichi Makino et al.
PLOS ONE (2012)
EMT as the ultimate survival mechanism of cancer cells
Neha Tiwari et al.
SEMINARS IN CANCER BIOLOGY (2012)
Role and Relevance of TrkB Mutations and Expression in Non-Small Cell Lung Cancer
Taishi Harada et al.
CLINICAL CANCER RESEARCH (2011)
Brain-Derived Neurotrophic Factor and Neurotrophin-4/5 Are Expressed in Breast Cancer and Can Be Targeted to Inhibit Tumor Cell Survival
Elsa Vanhecke et al.
CLINICAL CANCER RESEARCH (2011)
BDNF/TrkB signaling as an anti-tumor target
Rafael Roesler et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2011)
Zeb1 is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis
M. A. Smit et al.
ONCOGENE (2011)
Overexpression of TrkB promotes the progression of colon cancer
Yingjiao Yu et al.
APMIS (2010)
Mutual Regulation of Src Family Kinases and the Neurotrophin Receptor TrkB
Yang Z. Huang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Tyrosine kinase B receptor and BDNF expression in ovarian cancers - Effect on cell migration, angiogenesis and clinical outcome
Christy W. H. Au et al.
CANCER LETTERS (2009)
On Trk-The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology
Carol J. Thiele et al.
CLINICAL CANCER RESEARCH (2009)
Trk Receptor Expression and Inhibition in Neuroblastomas
Garrett M. Brodeur et al.
CLINICAL CANCER RESEARCH (2009)
Revised FIGO staging for carcinoma of the endometrium
William Creasman
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2009)
Neurotrophic Receptor, Tropomyosin-Related Kinase B as an Independent Prognostic Marker in Gastric Cancer Patients
Koji Tanaka et al.
JOURNAL OF SURGICAL ONCOLOGY (2009)
A Twist-Snail Axis Critical for TrkB-Induced Epithelial-Mesenchymal Transition-Like Transformation, Anoikis Resistance, and Metastasis
Marjon A. Smit et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Anoikis resistance and tumor metastasis
Craig D. Simpson et al.
CANCER LETTERS (2008)
Suppression of anoikis by the neurotrophic receptor TrkB in human ovarian cancer
Xiaohui Yu et al.
CANCER SCIENCE (2008)
Overexpression of tyrosine kinase B protein as a predictor for distant metastases and prognosis in gastric carcinoma
Yong Zhang et al.
ONCOLOGY (2008)
Critical role for TrkB kinase function in anoikis suppression, tumorigenesis, and metastasis
Thomas R. Geiger et al.
CANCER RESEARCH (2007)
Hypoxia-inducible factor-1 (HIF-1) is a transcriptional activator of the TrkB neurotrophin receptor gene
Lina K. Martens et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Tyrosine receptor kinase B (TrkB) protein expression in the human endometrium
Dana L. Anger et al.
ENDOCRINE (2007)
Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility
C. C. Thompson et al.
GUT (2007)
Oncogenic Ras inhibits anoikis of intestinal epithelial cells by preventing the release of a mitochondrial pro-apoptotic protein Omi/HtrA2 into the cytoplasm
Zaiping Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Brain-derived neurotrophic factor activation of TrkB induces vascular endothelial growth factor expression via hypoxia-inducible factor-1α in neuroblastoma cells
K Nakamura et al.
CANCER RESEARCH (2006)
High twist expression is involved in infiltrative endometrial cancer and affects patient survival
S Kyo et al.
HUMAN PATHOLOGY (2006)
Biological effects of TrkA and TrkB receptor signaling in neuroblastoma
A Schramm et al.
CANCER LETTERS (2005)
Molecular requirements for epithelial-mesenchymal transition during tumor progression
MA Huber et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
The neurotrophic receptor TrkB in anoikis resistance and metastasis: A prespective
TR Geiger et al.
CANCER RESEARCH (2005)
A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival
RN Pearse et al.
BLOOD (2005)
Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB
S Douma et al.
NATURE (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Share Paper
